期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

强迫症治疗的定性评估和难治性强迫症的治疗策略

下载PDF
导出
摘要 本文综述了强迫症治疗定性评估的最新认识和难治性强迫症治疗策略的最新研究进展。
作者 苏中华 成义仁
机构地区 山东省济宁市精神病防治院
出处 《山东精神医学》 2005年第3期201-203,共3页 Shangdong Archives of Psychiatry
关键词 强迫症 定性评估 治疗策略
分类号 R749.7 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献15

  • 1苏中华.强迫谱系障碍[J].国外医学（精神病学分册）,2003,30(2):113-116. 被引量：12
  • 2Hollander E,Zohar J.Introduction:beyond refractory obsessions and anxiety states:towards remission[J].J Clin Psychiatry,2004,65(suppl 14):1～5 被引量：1
  • 3Pallanti S,Hollander E,Bienstock C,et al.Treatment non-response in OCD:methodological issues and operational definitions[J].Int J Neuropsychopharmacol,2002,5(2):181～191 被引量：1
  • 4Ebert M,Loosen PT,Nurcombe B.Current diagnosis & treatment in psychiatry[M].McGraw Hill Companies Inc,2000 被引量：1
  • 5Hollander E,Koran LM,Goodman WK,et al.A double-blind,placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder[J].J Clin Psychiatry,2003,64(6):640～647 被引量：1
  • 6Pallanti S,Hollander E,Goodman WK.A qualitative analysis of nonresponse:management of treatment-refractory obsessive-compulsive disorder[J].J Clin Psychiatry,2004,65(suppl 14):6～10 被引量：1
  • 7Hollander E,Bienstock CA,Koran LM,et al.Refractory obsessive-compulsive disorder:state-of-the-art treatment[J].J Clin Psychiatry,2002,63(suppl 6):20～29 被引量：1
  • 8Ravizzal L,Albert U,Ceregato A.Venlafaxine in OCD.Presented at the 5th International Obsessive-compulsive disorder[C].2001,March,Sardinia,Italy 被引量：1
  • 9Hollander E,Friedberg J,Wasserman S,et al.Venlafaxine in treatment resistant obsessive-compulsive disorder[J].J Clin Psychiatry,2003,64(5):546～550 被引量：1
  • 10Shapira NA,Ward HE,Mandoki M,et al.A double-blind,placebo-controlled trial of olanzapine addition in fluoxeitine-refractory obsessive-compulsive disorder[J].Biol Psychiatry,2004,55(5):553～555 被引量：1

二级参考文献15

  • 1Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am, 2000, 23:563-586. 被引量：1
  • 2Richelson E. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry, 1996, 57 Suppl 11:4-11. 被引量：1
  • 3Gabriels L, Cosyns P, Nuttin B, et al. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopa-thological and neuropsychological outcome in three cases. Acta Psychiatr Scand, 2003, 107:275-282. 被引量：1
  • 4Flament MF, Bisserbe JC. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies. J Clin Psychiatry, 1997, 58 Suppl 12:18-22. 被引量：1
  • 5Hollander E, Kaplan A, Allen A, et al. Pharmacotherapy for obsessive-compulsive disorder. Psychiatr Clin North Am, 2000, 23:643-656. 被引量：1
  • 6Gorman JM, Kent JM. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression. J Clin Psychiatry, 1999, 60 Suppl 4:33-38. 被引量：1
  • 7Hollander E, Bienstock CA, Koran LM, et al. Refractory obsessive-compulsive disorder: state-of-the-art treatment. J Clin Psychiatry, 2002, 63 Suppl 6:20-29. 被引量：1
  • 8McDougle CJ. Update on pharmacologic management of OCD: agents and augmentation. J Clin Psychiatry, 1997, 58 Suppl 12:11-17. 被引量：1
  • 9Pigott TA. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry, 1999, 60 Suppl 18:4-15. 被引量：1
  • 10Stein DJ. Advances in the neurobiology of obsessive-compulsive disorder:implications for conceptualizing putative obsessive-compulsive and spectrum disorders. Psychiatr Clin North Am, 2000, 23:545-562. 被引量：1

共引文献74

山东精神医学
2005年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部